DeepIntent Platform
Provider 
Founded —
Ownership —

DeepIntent is a healthcare advertising demand-side platform for pharma.
DeepIntent is a healthcare advertising demand-side platform purpose-built for the pharmaceutical industry, offering verified HCP and patient audience targeting across omnichannel formats including CTV, audio, display, video, DOOH, and EHR. The platform's patented Outcomes Optimization AI aligns ad impressions to real-world prescription lift, reaching 98% of prescribing HCPs.
DeepIntent was acquired by Propel Media and remains a Propel Media subsidiary after IQVIA's attempted acquisition was blocked by the FTC in December 2023. The platform differentiates from Pathwai through its full DSP capabilities with self-service media buying and healthcare-specific measurement like script lift and audience quality, while Pathwai focuses on audience identification and activation using non-sensitive demographic signals rather than clinical data partners like IQVIA Digital and Symphony Health.
| Attribute | DeepIntent Platform | Pathwai | |
|---|---|---|---|
| Provider | |||
| Founded | — | 2024 | |
| Ownership | — | Venture-backed |
Provider 
Founded —
Ownership —
Provider 
Founded 2024
Ownership Venture-backed
HABi is a privacy-forward health demand-side platform covering 90%+ of the US population.


OptimizeRx is a dynamic audience activation platform for pharma marketing.


Swoop is an AI-driven predictive audience targeting platform for pharma commercialization.


Prognos Factor is an omnichannel pharma marketing platform using real-world data.
HABi is a privacy-forward health demand-side platform covering 90%+ of the US population.
OptimizeRx is a dynamic audience activation platform for pharma marketing.
Swoop is an AI-driven predictive audience targeting platform for pharma commercialization.

Prognos Factor is an omnichannel pharma marketing platform using real-world data.
